Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (8560)	5/26/1998 6:45:00 PM
From: EyeDrMike	Read Replies (1) \| Respond to of 23519

<< When viagra was introduced total muse scripts were 13000 per week and I assume at a peak. This is half my estimate of 26603.>> i have seen reports stating IMS data only tracks about 60% of all written scripts, and i believe VVUS had "peak weeks" higher than 13000. I know in the past, the script data for every week in the last 14 months was posted. Mike

To: DaiS who wrote (8560)	5/26/1998 7:04:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

DaiS, A few things to consider: weekly script total was about 15,000 before Viagra came out (month of March) did you include milestone payments in total revenues? As far as script numbers is concerned remember what Edderd said--often the first new script is for only one or two doses while the patient is getting titrated. Refill will usually be for those who are already titrated and would be for 6 doses. Total unit sales have much more meaning than script numbers. Most of the income will be from refills which have not been effected as badly as new scripts. Remember, refills are usually for 6 doses and new scripts are often for only 1 or 2 doses.